Stock ALNY ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Governance Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/01/2025 GMT 		5-day change 1st Jan Change
264.99 USD +7.60% Intraday chart for Alnylam Pharmaceuticals, Inc. +2.60% +12.61%
01-13 Alnylam Pharmaceuticals, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 09:45 AM
01-12 Alnylam Pharmaceuticals, Inc. Provides Earnings Guidance for Full Year 2025 CI

Executive Committee: Alnylam Pharmaceuticals, Inc.

Manager
Positions heldSince
Yvonne Greenstreet

Yvonne Greenstreet

62 year

Chief Executive Officer 31/12/2021
Timothy J. Maines

Timothy J. Maines

Chief Tech/Sci/R&D Officer 31/03/2023
Piyush Sharma

Piyush Sharma

Compliance Officer 20/09/2022
Jeffrey Poulton

Jeffrey Poulton

57 year

Director of Finance/CFO 12/08/2019
Kelley Boucher

Kelley Boucher

Human Resources Officer 28/05/2019
Kevin Fitzgerald

Kevin Fitzgerald

57 year

Chief Tech/Sci/R&D Officer 31/08/2016
Pushkal Garg

Pushkal Garg

57 year

Chief Tech/Sci/R&D Officer 28/10/2014
Christine Regan Lindenboom

Christine Regan Lindenboom

44 year

Investor Relations Contact 31/08/2015
Public Communications Contact 31/08/2015
James Bilotta

James Bilotta

Chief Tech/Sci/R&D Officer 30/09/2015
Alan Eisenberg

Alan Eisenberg

General Counsel 08/05/2017
Robert Hesslein

Robert Hesslein

72 year

General Counsel 31/08/2024
Corporate Secretary 31/08/2024

Composition of the Board of Directors: Alnylam Pharmaceuticals, Inc.

Director
CommitteesSince
Amy Schulman

Amy Schulman

64 year

Governance Committee 31/08/2018
Nominating Committee 31/08/2018
Compensation Committee 30/06/2015
Audit Committee 24/01/2021
Compensation Committee Chair 24/01/2021
David Pyott

David Pyott

71 year

Executive Committee 06/04/2011
Governance Committee Chair
Nominating Committee Chair
Compensation Committee
Governance Committee 03/01/2016
Nominating Committee 03/01/2016
Audit Committee
Colleen Reitan

Colleen Reitan

65 year

Audit Committee 24/09/2019
Compensation Committee Chair
HR Committee Chair
Compensation Committee 25/08/2019
Finance Committee 24/09/2019
Governance Committee Chair 24/09/2019
Nominating Committee Chair 24/09/2019
Dennis Ausiello

Dennis Ausiello

79 year

Governance Committee 25/04/2021
Nominating Committee 29/12/2021
Audit Committee 29/12/2021
Finance Committee 29/12/2021
Compensation Committee 29/12/2021
Charles Sigal

Charles Sigal

73 year

Governance Committee 07/06/2020
Nominating Committee 07/06/2020
Compensation Committee
HR Committee
Carolyn Bertozzi

Carolyn Bertozzi

58 year

Governance Committee 04/01/2023
Nominating Committee 04/01/2023
Compensation Committee
Olivier Brandicourt

Olivier Brandicourt

68 year

Audit Committee 21/01/2024
Compensation Committee 01/03/2020
HR Committee 01/03/2020
Margaret Hamburg

Margaret Hamburg

69 year

Governance Committee 09/01/2019
Nominating Committee 09/01/2019
Peter Kellogg

Peter Kellogg

67 year

Audit Committee 11/05/2021
Audit Committee Chair 28/09/2023
Phillip Sharp

Phillip Sharp

80 year

Executive Committee
Compensation Committee 31/12/2016
Michael Bonney

Michael Bonney

66 year

Director/Board Member 04/01/2023
Yvonne Greenstreet

Yvonne Greenstreet

62 year

Director/Board Member 27/10/2021

Latest Appointments: Alnylam Pharmaceuticals, Inc.

TransMedics Names Gerardo Hernandez as CFO; Shares Fall 12-03 MT
TransMedics Names Gerardo Hernandez as CFO; Updates Full Year 2024 Guidance 12-02 MT
KalVista Pharmaceuticals, Inc. Appoints Laurence Reid to Board of Directors 11-26 CI
Lexeo Therapeutics, Inc. Appoints Tolga Tanguler to Its Board of Directors 11-13 CI
Cognizant Selected as Alnylam's IT Services Provider 29/10/24 MT
Alnylam Pharmaceuticals, Inc. Announces Transition of Indrani L. Franchini as Executive Vice President, Chief Legal Officer and Secretary, Effective on March 1, 2024 19/01/24 CI
Marsha H. Fanucci Resigns from Board of Directors of Alnylam Pharmaceuticals, Inc 28/09/23 CI
More news

Former Officers and Directors: Alnylam Pharmaceuticals, Inc.

Insider
Positions held
SinceUntil
Marsha Fanucci
Marsha Fanucci
Director/Board Member 07/12/2010 28/09/2023
Independent Dir/Board Member 07/12/2010 28/09/2023
Al Boyle
Al Boyle
Chief Tech/Sci/R&D Officer 30/11/2015 31/03/2023
Masako Nakamura
Masako Nakamura
Corporate Officer/Principal 19/06/2018 30/12/2022
Steven Paul
Steven Paul
Director/Board Member 21/09/2010 15/04/2022
Independent Dir/Board Member 21/09/2010 15/04/2022
John Maraganore
John Maraganore
Director/Board Member 30/11/2002 30/12/2021
Chief Executive Officer 30/11/2002 30/12/2021
Founder 30/11/2002 30/12/2021
President 30/11/2002 30/11/2007
Laurie Keating
Laurie Keating
General Counsel 16/09/2014 09/09/2021
Corporate Secretary 16/09/2014 09/09/2021
Jeff Miller
Jeff Miller
Corporate Officer/Principal 31/12/2015 28/02/2021
Barry Greene
Barry Greene
Chief Operating Officer 30/09/2003 18/09/2016
President 30/09/2003 29/09/2020
Jing Marantz
Jing Marantz
Corporate Officer/Principal 19/06/2018 31/08/2020
Jae Kim
Jae Kim
Corporate Officer/Principal 31/12/2015 30/06/2020
Paul Schimmel
Paul Schimmel
Director/Board Member 13/06/2002 05/05/2020
Founder 13/06/2002 05/05/2020
Independent Dir/Board Member 13/06/2002 05/05/2020
Theresa Heggie
Theresa Heggie
Corporate Officer/Principal 08/05/2017 30/04/2020
Nereyda Garcia
Nereyda Garcia
Compliance Officer 31/12/2015 30/11/2019
Manmeet Singh Soni
Manmeet Singh Soni
Comptroller/Controller/Auditor 08/10/2018 11/08/2019
Director of Finance/CFO 08/05/2017 11/08/2019
Mike Mason
Mike Mason
Comptroller/Controller/Auditor 30/11/2005 30/09/2018
Director of Finance/CFO 01/12/2005 31/05/2016
Treasurer 31/01/2011 31/01/2019
John Clarke
John Clarke
Director/Board Member 13/06/2002 09/01/2019
Chairman 13/06/2002 31/12/2015
Founder 13/06/2002 09/01/2019
Independent Dir/Board Member 13/06/2002 09/01/2019
Karen Anderson
Karen Anderson
Human Resources Officer 16/09/2014 31/12/2018
Kevin Starr
Kevin Starr
Director/Board Member 31/08/2003 28/02/2018
Independent Dir/Board Member 31/08/2003 28/02/2018
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino
Corporate Officer/Principal 31/12/2013 31/08/2017
Peter F. Smith
Peter F. Smith
Corporate Officer/Principal 08/05/2017 -
David-Alexandre Gros
David-Alexandre Gros
Director of Finance/CFO 30/06/2016 05/01/2017
Corporate Officer/Principal 07/06/2015 30/06/2016
Mark Baglin
Mark Baglin
Sales & Marketing 31/12/2016 -
Benny Sorensen
Benny Sorensen
Chief Tech/Sci/R&D Officer 30/06/2015 30/09/2016
Susanna High
Susanna High
Director/Board Member 31/01/2007 31/05/2008
Corporate Officer/Principal 31/05/2008 31/08/2016
Emmanuel Dulac
Emmanuel Dulac
Corporate Officer/Principal 18/08/2016 -
Oved Amitay
Oved Amitay
Corporate Officer/Principal 26/06/2012 31/05/2016
Arianna Greco
Arianna Greco
General Counsel 31/12/2015 -
Corporate Officer/Principal 31/12/2015 -
Laurence Reid
Laurence Reid
Corporate Officer/Principal 03/06/2010 30/12/2014
Marko Kinchen Kozul
Marko Kinchen Kozul
Corporate Officer/Principal 16/09/2014 -
Victor J. Dzau
Victor J. Dzau
Director/Board Member 31/03/2007 29/06/2014
Independent Dir/Board Member 31/03/2007 29/06/2014
Varun Kumar
Varun Kumar
Corporate Officer/Principal 31/03/2011 31/01/2014
Pritesh Gandhi
Pritesh Gandhi
Chief Tech/Sci/R&D Officer 31/12/2013 -
Aria Tavana
Aria Tavana
Corporate Officer/Principal 31/12/2012 -
Nessan Bermingham
Nessan Bermingham
Corporate Officer/Principal 29/04/2012 29/04/2012
Dinah Sah
Dinah Sah
Chief Tech/Sci/R&D Officer 31/03/2005 31/12/2011
Private Equity Investor 31/12/2009 31/12/2011
Kenneth S. Koblan
Kenneth S. Koblan
Chief Tech/Sci/R&D Officer 19/12/2010 01/06/2011
Corporate Officer/Principal 03/06/2010 19/12/2010
Vicki Sato
Vicki Sato
Director/Board Member 30/11/2005 29/04/2011
Patricia Allen
Patricia Allen
Director of Finance/CFO 30/04/2004 26/09/2010
Treasurer 30/04/2004 27/02/2011
James L. Vincent
James L. Vincent
Director/Board Member 30/06/2005 21/09/2010
Garvin L. Warner
Garvin L. Warner
Corporate Officer/Principal 31/07/2010 -
Ed Scolnick
Ed Scolnick
Director/Board Member 31/01/2008 31/01/2010
Jason Rhodes
Jason Rhodes
Corporate Officer/Principal 30/06/2007 31/12/2009
Antonin Rollet de Fougerolles
Antonin Rollet de Fougerolles
Chief Tech/Sci/R&D Officer 31/12/2002 31/12/2009
John Schmidt
John Schmidt
Chief Tech/Sci/R&D Officer 30/09/2008 29/09/2009
Peter J. Williams
Peter J. Williams
Corporate Officer/Principal 31/12/2005 -
Nagesh Mahanthappa
Nagesh Mahanthappa
Corporate Officer/Principal 31/07/2002 31/01/2007
Eric W. Raichle
Eric W. Raichle
Human Resources Officer 31/12/2006 -
Mary DeLena
Mary DeLena
Corporate Officer/Principal 31/12/2006 -
John Berriman
John Berriman
Director/Board Member 30/06/2003 06/12/2005
Cynthia Clayton
Cynthia Clayton
Investor Relations Contact 31/12/2004 -
Robert A. Millman
Robert A. Millman
Corporate Officer/Principal 08/09/2004 -
Lubomir Nechev
Lubomir Nechev
Corporate Officer/Principal 31/12/2003 -
Thomas R. Ulich
Thomas R. Ulich
Chief Tech/Sci/R&D Officer 31/12/2002 31/12/2003
Vincent J. Miles
Vincent J. Miles
Corporate Officer/Principal 30/06/2003 -
David M. Konys
David M. Konys
Corporate Officer/Principal 31/03/2003 -
Rachel Meyers
Rachel Meyers
Chief Tech/Sci/R&D Officer 31/03/2003 -
Victor E. Kotelianski
Victor E. Kotelianski
Corporate Officer/Principal 31/03/2003 -
Peter Barrett
Peter Barrett
Director/Board Member 30/06/2002 -
Akin Akinc
Akin Akinc
Corporate Officer/Principal - -
David Altreuter
David Altreuter
Corporate Officer/Principal - -
Mary D. Trueblood
Mary D. Trueblood
Comptroller/Controller/Auditor - -
Zachary A. Zimmerman
Zachary A. Zimmerman
Corporate Officer/Principal - -
Jian Xin Chen
Jian Xin Chen
Corporate Officer/Principal - -
Jürgen Soutschek
Jürgen Soutschek
Chief Tech/Sci/R&D Officer - -
Edward E. Harlow
Edward E. Harlow
Corporate Officer/Principal - -
Eric Ruby
Eric Ruby
General Counsel - -
Roy R. Lobb
Roy R. Lobb
Corporate Officer/Principal - -
David Neafus
David Neafus
Director of Finance/CFO - -
Ulrich Bodner
Ulrich Bodner
Corporate Officer/Principal - -
Stuart Pollard
Stuart Pollard
Corporate Officer/Principal - -
Donna T. Ward
Donna T. Ward
Corporate Officer/Principal - -
Jeffrey Behrens
Jeffrey Behrens
Corporate Officer/Principal - -
Kathryn Morris
Kathryn Morris
Public Communications Contact - -
Philip T. Chase
Philip T. Chase
General Counsel - -
Christoph Westphal
Christoph Westphal
Director/Board Member - -
Founder - -
Marika St Amand
Marika St Amand
Human Resources Officer - -

Age distribution of managers

Parity Men Women

Male 29
Female 5

Of which Executive Committee

Male 9
Female 2

Of which Directors

Male 10
Female 2
ESG MSCI
A

ESG

Environment
Social
Governance
Controversy

Company Profile

Logo Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. In addition, the Company develops Cemdisiran to treat complement-mediated diseases, Belcesiran for the treatment of alpha-1 liver disease, Elebsiran, Zilebesiran, ALN-APP, ALN-HSD, Fitusiran, and others.
Employees
2,100
Sector
Pharmaceuticals
Calendar
05/02/2025 - Q4 2024 Earnings Release (Projected)
More about the company

Departures of Key Persons

John Clarke
-
John Clarke

John Maraganore
-
John Maraganore

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. Company Alnylam Pharmaceuticals, Inc.
  5. Governance
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition